BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 3:10:00 PM | Browse: 618 | Download: 573
Publication Name World Journal of Hepatology
Manuscript ID 10769
Country/Territory Italy
Received
2014-04-18 10:55
Peer-Review Started
2014-04-18 16:05
To Make the First Decision
2014-05-14 13:45
Return for Revision
2014-05-16 15:10
Revised
2014-06-12 07:48
Second Decision
2014-06-27 17:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-27 17:59
Articles in Press
2014-06-27 18:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-22 17:27
Publish the Manuscript Online
2014-07-25 16:43
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Autobiography
Article Title CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Manuscript Source Unsolicited Manuscript
All Author List Sila Cocciolillo, Giustino Parruti and Leonardo Marzio
Funding Agency and Grant Number
Corresponding Author Sila Cocciolillo, MD, Digestive Physiopathology Unit, Gabriele d’Annunzio University, Pescara Civic Hospital, Via Fonte Romana 8, 65124 Pescara, Italy. s_sila2000@yahoo.it
Key Words Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Contrast-enhanced ultrasound; Fibroscan; Hepatic blood flow; Liver stiffness
Core Tip The use of contrast-enhanced ultrasound (CEUS) assisted by dedicated software (Qontrast?) in combination with Fibroscan examination could provide a non-invasive tool to evaluate the level of fatty-liver disease. In this study, we found that there were reductions in portal and intra-parenchymal blood flow in patients affected by non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH), whereas liver stiffness was increased only in NASH patients. Qontrast?-assisted CEUS could be used to quantify early changes in intra-parenchymal liver flow before the onset of fibrosis.
Publish Date 2014-07-25 16:43
Citation Cocciolillo S, Parruti G, Marzio L. CEUS and Fibroscan in nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. World J Hepatol 2014; 6(7): 496-503
URL http://www.wjgnet.com/1948-5182/full/v6/i7/496.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i7.496
Full Article (PDF) WJH-6-496.pdf
Full Article (Word) WJH-6-496.doc
Manuscript File 10769-Review.docx
Answering Reviewers 10769-Answering reviewers.pdf
Copyright License Agreement 10769-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 10769-Language certificate.pdf
Peer-review Report 10769-Peer review(s).pdf
Scientific Misconduct Check 10769-CrossCheck.jpg
Scientific Editor Work List 10769-Scientific editor work list.pdf